Table 2.
Clinical parameter | CC area I tracts | CC area II tracts | CC area III tracts | CC area IV tracts | CC area V tracts | |
---|---|---|---|---|---|---|
C9orf72-associated ALS | Disease duration | −0.21 | −0.09 | −0.51* | −0.14 | −0.11 |
ALS-FRS-R | −0.04 | 0.12 | 0.40* | −0.19 | −0.02 | |
UMN burden score | −0.02 | −0.43* | −0.61* | 0.00 | −0.10 | |
Sporadic ALS | Disease duration | 0.25 | 0.09 | −0.01 | 0.07 | 0.27 |
ALS-FRS-R | 0.23 | 0.39 | 0.43* | 0.20 | 0.14 | |
UMN burden score | −0.36 | −0.56* | −0.52* | −0.38 | −0.31 |
Significant correlation.
ALS, amyotrophic lateral sclerosis ; ALS-FRS-R, revised ALS functional rating scale; CC, corpus callosum; FA, fractional anisotropy; TFAS, tractwise fractional anisotropy statistics; UMN, upper motor neuron.